CSL Behring Medical Expert Portal is a global web portal designed for healthcare professionals (HCPs) outside the US who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available for your country. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. Product labels may vary from country to country. Please ensure to follow the applicable label for your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Science updates

25 Mar 2024

EAHAD 2024 catch-up: access the latest findings on gene therapy in haemophilia

Pathology:

Haemophilia B

The European Association for Haemophilia and Allied Disorders (EAHAD) Congress 2024 took place last month, where CSL Behring sponsored the symposium ‘Unlocking the next step in gene therapy for haemophilia: The end of the beginning?’ and released new long-term longevity data for AMT-060 and etranacogene dezaparvovec (AMT-061).

For those who could not attend, or would like to watch the symposium again, the symposium recording is now available to watch on-demand here.